rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-2-26
|
pubmed:abstractText |
To evaluate the efficacy and safety of docetaxel in heavily pretreated and anthracycline-resistant patients with metastatic breast cancer in an outpatient setting.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author |
pubmed-author:BlackNN,
pubmed-author:BrodowiczTT,
pubmed-author:BudinskyA CAC,
pubmed-author:HojasSS,
pubmed-author:IlsingerPP,
pubmed-author:KubistaEE,
pubmed-author:LockerG JGJ,
pubmed-author:MaceWW,
pubmed-author:PluschnigUU,
pubmed-author:SchmidingerMM,
pubmed-author:SeewannLL,
pubmed-author:StegerG GGG,
pubmed-author:WenzelCC,
pubmed-author:ZaberniggAA,
pubmed-author:ZielinskiC CCC
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-62
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11221963-Adolescent,
pubmed-meshheading:11221963-Adult,
pubmed-meshheading:11221963-Aged,
pubmed-meshheading:11221963-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:11221963-Breast Neoplasms,
pubmed-meshheading:11221963-Child,
pubmed-meshheading:11221963-Child, Preschool,
pubmed-meshheading:11221963-Disease-Free Survival,
pubmed-meshheading:11221963-Drug Administration Schedule,
pubmed-meshheading:11221963-Feasibility Studies,
pubmed-meshheading:11221963-Female,
pubmed-meshheading:11221963-Humans,
pubmed-meshheading:11221963-Middle Aged,
pubmed-meshheading:11221963-Paclitaxel,
pubmed-meshheading:11221963-Taxoids
|
pubmed:year |
2001
|
pubmed:articleTitle |
Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial.
|
pubmed:affiliation |
Department of Medicine I, University Hospital of Vienna, Austria. manuela.schmidinger@a-topmail.at
|
pubmed:publicationType |
Journal Article
|